Literature DB >> 19609728

Regulation of P2X(7) gene transcription.

Lingyin Zhou1, Liping Luo, Xiaoping Qi, Xin Li, George I Gorodeski.   

Abstract

The pro-apoptotic P2X(7) receptor regulates growth of epithelial cells. The objectives of the study were to understand P2X(7) gene transcription; to identify the active promoter and the transcription initiation site (TpIS); and to begin understanding regulation of P2X(7) gene transcription. Experiments in vitro utilized normal and cancerous cultured human uterine cervical epithelial cells, and HEK293 cells overexpressing P2X(7)-luciferase reporters. Experiments in vivo used surgical specimen of normal and cancerous uterine cervix. Assays involved DNA, RNA, and protein techniques. (a) The P2X(7) TpIS was localized to adenine (+1) at nt 1683 of the human P2X(7) gene [GenBank Y12851]), with a TTAAA sequence at nt -32/-28 and an active promoter region within nt -158/+32. (b) P2X(7) transcription was found to be regulated by two enhancers located at nt + 222/+232 and +401/+573 regions downstream of the active P2X(7) promoter. (c) The putative enhancer regions formed four DNA-protein complexes. (d) P2X(7) transcription was found to be controlled by hypermethylated cytosines at cytosine-phosphodiester-guanosines (CpG) that cluster or co-localize with the enhancers' sites. (e) We identified nine CpGs as inhibitory cis elements, and three CpG sites that are hypermethylated in cultured cervical epithelial cells and in cervix epithelia in vivo. (f) In cancer cervical cells, the degree of hypermethylation of the CpG sites was greater than in the normal cervical cells. Expression of the P2X(7) receptor is controlled by hypermethylated CpGs that flank transcription enhancers located within a 547-nt region downstream of the promoter.

Entities:  

Year:  2009        PMID: 19609728      PMCID: PMC2717324          DOI: 10.1007/s11302-009-9167-x

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  78 in total

1.  Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation.

Authors:  William H Loomis; Sachiko Namiki; Rennolds S Ostrom; Paul A Insel; Wolfgang G Junger
Journal:  J Biol Chem       Date:  2002-12-02       Impact factor: 5.157

Review 2.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

3.  Assessment of gene promoter hypermethylation for detection of cervical neoplasia.

Authors:  G Bea A Wisman; Esther R Nijhuis; Mohammad O Hoque; Nathalie Reesink-Peters; Alice J Koning; Haukeline H Volders; Henk J Buikema; H Marike Boezen; Harry Hollema; Ed Schuuring; David Sidransky; Ate G J van der Zee
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

4.  Pannexin1 is part of the pore forming unit of the P2X(7) receptor death complex.

Authors:  Silviu Locovei; Eliana Scemes; Feng Qiu; David C Spray; Gerhard Dahl
Journal:  FEBS Lett       Date:  2007-01-16       Impact factor: 4.124

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

Review 6.  Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment.

Authors:  Salvador Rodriguez-Nieto; Boris Zhivotovsky
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

7.  Decreased expression of P2X7 in endometrial epithelial pre-cancerous and cancer cells.

Authors:  Xin Li; Xiaoping Qi; Lingyin Zhou; Deborah Catera; Neal S Rote; Judith Potashkin; Fadi W Abdul-Karim; George I Gorodeski
Journal:  Gynecol Oncol       Date:  2007-05-04       Impact factor: 5.482

8.  P2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin.

Authors:  Xin Li; Xiaoping Qi; Lingyin Zhou; Wen Fu; Fadi W Abdul-Karim; Gregory Maclennan; George I Gorodeski
Journal:  Purinergic Signal       Date:  2009-04-28       Impact factor: 3.765

Review 9.  Regulation in S phase by E2F.

Authors:  Arthur B Pardee; Chiang J Li; G Prem Veer Reddy
Journal:  Cell Cycle       Date:  2004-09-04       Impact factor: 4.534

10.  Activation of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice.

Authors:  Wen Fu; Tom McCormick; Xiaoping Qi; Liping Luo; Lingyin Zhou; Xin Li; Bing-Cheng Wang; Heidi E Gibbons; Fadi W Abdul-Karim; George I Gorodeski
Journal:  BMC Cancer       Date:  2009-04-20       Impact factor: 4.430

View more
  10 in total

Review 1.  The role of P2X7 receptors in tissue fibrosis: a brief review.

Authors:  Daniela Gentile; Mariarita Natale; Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Franco Laghi-Pasini
Journal:  Purinergic Signal       Date:  2015-08-29       Impact factor: 3.765

Review 2.  Purinergic signalling in the reproductive system in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-23       Impact factor: 3.765

3.  ERK pathway mediates P2X7 expression and cell death in renal interstitial fibroblasts exposed to necrotic renal epithelial cells.

Authors:  Murugavel Ponnusamy; Na Liu; Rujun Gong; Haidong Yan; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-15

4.  Epigenetic alteration of the purinergic type 7 receptor in salivary epithelial cells.

Authors:  Yong-Hwan Shin; Minkyoung Kim; Nahyun Kim; Seul-Ki Choi; Eun Namkoong; Se-Young Choi; Jong-Ho Lee; Seunghee Cha; Kyungpyo Park
Journal:  Biochem Biophys Res Commun       Date:  2015-09-21       Impact factor: 3.575

Review 5.  Research Progress in the Relationship Between P2X7R and Cervical Cancer.

Authors:  Yiqing Tang; Cuicui Qiao; Qianqian Li; Xiaodi Zhu; Ronglan Zhao; Xiaoxiang Peng
Journal:  Reprod Sci       Date:  2022-07-07       Impact factor: 3.060

Review 6.  The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease.

Authors:  Hanne Leysen; Deborah Walter; Lore Clauwaert; Lieselot Hellemans; Jaana van Gastel; Lakshmi Vasudevan; Bronwen Martin; Stuart Maudsley
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

Review 7.  P2X7Rs: new therapeutic targets for osteoporosis.

Authors:  Haoyun Huang; Yu-Mei He; Miao-Miao Lin; Yanchao Wang; Xiaomei Zhang; Li Liang; Xueling He
Journal:  Purinergic Signal       Date:  2022-02-02       Impact factor: 3.765

8.  miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2X7 receptor.

Authors:  Songyin Huang; Yongsong Chen; Wei Wu; Nengyong Ouyang; Jianing Chen; Hongyu Li; Xiaoqiang Liu; Fengxi Su; Ling Lin; Yandan Yao
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

9.  The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system.

Authors:  Paula García-Huerta; Miguel Díaz-Hernandez; Esmerilda G Delicado; María Pimentel-Santillana; M Teresa Miras-Portugal; Rosa Gómez-Villafuertes
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

10.  Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model.

Authors:  Deidiane Elisa Ribeiro; Plinio C Casarotto; Laura Staquini; Maria Augusta Pinto E Silva; Caroline Biojone; Gregers Wegener; Samia Joca
Journal:  PeerJ       Date:  2019-10-21       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.